Investors sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading hours on Tuesday after an insider sold shares in the company. $149.84 million flowed into the stock on the tick-up and $221.32 million flowed out of the stock on the tick-down, for a money net flow of $71.48 million out of the stock. Of all equities tracked, UnitedHealth Group had the 13th highest net out-flow for the day. UnitedHealth Group traded up $1.73 for the day and closed at $226.78Specifically, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the transaction, the director now directly owns 1,790,567 shares of the company’s stock, valued at $434,302,025.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Larry C. Renfro sold 22,184 shares of the company’s stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $228.94, for a total value of $5,078,804.96. Following the transaction, the insider now directly owns 173,229 shares of the company’s stock, valued at $39,659,047.26. The disclosure for this sale can be found here. Insiders have sold 67,015 shares of company stock valued at $15,635,599 over the last ninety days. 0.89% of the stock is owned by insiders.
Several research analysts have recently weighed in on the company. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Friday, March 9th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $280.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 8th. Barclays assumed coverage on UnitedHealth Group in a research report on Thursday, March 8th. They set an “overweight” rating and a $265.00 price target for the company. Finally, Argus increased their price target on UnitedHealth Group to $270.00 and gave the company a “buy” rating in a research report on Thursday, January 18th. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $245.14.
The firm has a market capitalization of $220,491.67, a PE ratio of 21.17, a PEG ratio of 1.33 and a beta of 0.74. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same period last year, the firm posted $2.11 earnings per share. The business’s revenue was up 9.5% on a year-over-year basis. sell-side analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.32%. UnitedHealth Group’s payout ratio is 28.01%.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. KBC Group NV lifted its position in shares of UnitedHealth Group by 4.7% in the third quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock valued at $63,416,000 after buying an additional 14,672 shares during the last quarter. DekaBank Deutsche Girozentrale increased its stake in shares of UnitedHealth Group by 2.0% during the third quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock worth $95,646,000 after purchasing an additional 9,810 shares during the period. Bainco International Investors increased its stake in shares of UnitedHealth Group by 5.4% during the third quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock worth $16,192,000 after purchasing an additional 4,202 shares during the period. Toronto Dominion Bank increased its stake in shares of UnitedHealth Group by 69.1% during the third quarter. Toronto Dominion Bank now owns 383,943 shares of the healthcare conglomerate’s stock worth $75,193,000 after purchasing an additional 156,892 shares during the period. Finally, Norinchukin Bank The increased its stake in shares of UnitedHealth Group by 2.7% during the third quarter. Norinchukin Bank The now owns 180,773 shares of the healthcare conglomerate’s stock worth $35,405,000 after purchasing an additional 4,838 shares during the period. 86.78% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.thestockobserver.com/2018/03/20/investors-sell-unitedhealth-group-unh-on-strength-on-insider-selling.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.